ライフサイエンスコーパス: compliance

1 in both cardiac performance and ventricular compliance.

2 atrophy, affecting quality of life and drug compliance.

3 st results or be associated with low patient compliance.

4 ieving optimal efficacy, safety, and patient compliance.

5 cal response, quality of life, toxicity, and compliance.

6 n their own care, and doing so improves CPAP compliance.

7 d microsensor objectively measured treatment compliance.

8 The device was used on 96% of days with good compliance.

9 gh vascular resistance, edema, and worsening compliance.

10 which were dependent on the dose of iron and compliance.

11 The exposure was full 3-hour bundle compliance.

12 y factors that contribute to failure of PIMT compliance.

13 ospital acquired pressure injury and turning compliance.

14 piratory effort and improved lung volume and compliance.

15 on and blood pressure despite high treatment compliance.

16 rms using acceleration trade-offs to achieve compliance.

17 t education regarding dietary and medication compliance.

18 s that may explain differences in daily MVPA compliance.

19 erved therapy improved treatment outcome and compliance.

20 ssures, hypercarbia, and decreased pulmonary compliance.

21 allergen-induced AHR, airway resistance, and compliance.

22 ing the cost of monitoring, enforcement, and compliance.

23 sures in fisheries and better enforcement of compliance.

24 y between peripheral arteries with different compliance.

25 .98) and sleeping (RR = 0.96) had the lowest compliance.

26 lindness, is challenging due to poor patient compliance.

27 of allergen-specific IgG4 as a biomarker for compliance.

28 to be statistically associated with level of compliance.

29 -alveolar vessels with decreased respiratory compliance.

30 plications of pesticides, leading to MRL non-compliances.

31 igh compliance (3-6 bundle elements) and low compliance (0-2 bundle elements) had a risk-adjusted SSI

32 seline, LF patients had lower total arterial compliance (0.36 +/- 0.12 ml/m(2)/mm Hg vs. 0.48 +/- 0.1

33 0.22 vs 0.58 +/- 0.17 mm Hg/mL; p = 0.710), compliance (1.19 +/- 0.8 vs 1.50 +/- 0.27 mL/mm Hg; p =

34 n the following categories according to PIMT compliance: 1) regular compliers (RC) (>/=2 PIMT/year);

35 ume (2.9-4 ml/kg ideal body weight) and poor compliance (12.1-18.7 ml/cm H2O) were noted, with signif

36 associated with improved dynamic respiratory compliance (17.3 +/- 2.6 vs 10.5 +/- 1.3 mL/cm H2O; p <

37 High compliance (3-6 bundle elements) and low compliance (0-2

38 he majority of patients demonstrated partial compliance (71% to 80% of patients).

39 interquartile range of 1/pulmonary arterial compliance; 95% CI, 1.02-1.37; p = 0.03) and pulmonary v

40 ermine the association between ABCDEF bundle compliance accounting for total compliance (all or none)

41 ring follow-up, including pulmonary arterial compliance, after initial management in PAH.

42 medication packaging than multi-compartment compliance aids (9.3% and 3.1% respectively, risk ratio

43 mon practice of using both multi-compartment compliance aids (for most medications) and original pack

44 aging-only care homes) and multi-compartment compliance aids (RR=2.3, 95%CI 1.1 to 4.9, p=0.03), and

45 ckaging and five used both multi-compartment compliance aids and original medication packaging).

46 l medication packaging and multi-compartment compliance aids in care homes, using direct observation.

47 l medication packaging and multi-compartment compliance aids on medication administration accuracy.

48 l medication packaging and multi-compartment compliance aids supports the use of the latter in care h

49 l medication packaging and multi-compartment compliance aids within care homes that used a combinatio

50 ation packaging, 1067 from multi-compartment compliance aids).

51 vival and quality of life influenced by lung compliance, albeit while accelerating disease progressio

52 BCDEF bundle compliance accounting for total compliance (all or none) or for partial compliance ("dos

53 The primary outcome was overall compliance along with adherence to individual quality-of

54 cellulose interaction and reductions in wall compliances along the apical-to-basal gradient in growth

55 ure, mean arterial pressure, lactate, bundle compliance, amount of fluid administered, and hemodynami

56 itation bundle was associated with increased compliance and a persistent reduction in 90-day mortalit

57 Compliance and body mass index did not modify the treatm

58 spital characteristics and prevention bundle compliance and changes in MDRO infection rates.

59 nsor, increasing the total time with turning compliance and demonstrated a statistically significant

60 Compliance and dimensionality mechanosensing, the proces

61 sted the hypothesis that MCAK contributes to compliance and dimensionality mechanosensing-mediated re

62 ve reflections at rest and improved arterial compliance and elastance and central hemodynamics during

63 ing the relation between half-sarcomere (hs) compliance and force during the force development follow

64 ted from the relation between half-sarcomere compliance and force during the force redevelopment afte

65 EF subjects displayed reduced total arterial compliance and higher effective arterial elastance despi

66 ultiple daily injections that reduce patient compliance and increase treatment cost.

67 d of care soluble iron salts, leading to non-compliance and ineffective correction of iron-deficiency

68 Here, we take advantage of the high compliance and large elastic deformability of a soft pol

69 instructed to collect data on 6-hour bundle compliance and outcomes in patients with sepsis in all h

70 study the association between ABCDEF bundle compliance and outcomes including hospital survival and

71 Audit of process compliance and patient outcomes are important features.

72 level, it was shown that association between compliance and peri-implant condition was statistically

73 d SUP varied significantly according to PIMT compliance and peri-implant condition.

74 es by increasing the total time with turning compliance and preventing pressure injuries in acutely i

75 e to antituberculous drugs is driven by poor compliance and programmatic failure is now being questio

76 Baseline measures of pulmonary arterial compliance and pulmonary vascular resistance predict mor

77 s promote weight gain, which can lead to non-compliance and relapse of psychosis.

78 Pulmonary arterial compliance and right ventricular load improve over time

79 , the reservoir pressure related to arterial compliance and the excess pressure caused by arterial wa

80 , the reservoir pressure related to arterial compliance and the excess pressure caused by waves incre

81 alization period, and improvement of patient compliance and therapeutic outcomes.

82 Optimization of therapy (improving compliance and timing of PPI doses), or increasing PPI d

83 ung function (specifically quasi-static lung compliance and tissue elastance) and reduced mucus produ

84 bactericidal activity and efficacy under non-compliance and treatment interruption.

85 re, cell wall thickness, and wall mechanical compliances and coupled these macroscopic measurements w

86 s, randomization, objective documentation of compliance, and analyses of treatment mediators that wil

87 k of bias, cluster versus individual trials, compliance, and attrition.

88 ess, alveolar simplification, decreased lung compliance, and decreased lung angiogenesis.

89 ed morbidity and viral burden, improved lung compliance, and increased CD8(+) T cell numbers in the a

90 ercise, increased wave reflections, impaired compliance, and increased resistance and elastance were

91 , continuous positive airway pressure (CPAP) compliance, and physician decision making.

92 ular gradients, decreased pulmonary arterial compliance, and reduced right ventricular function.

93 sistance (Z0), effective arterial elastance, compliance, and reflected pressure waves.

94 nary artery resistance, effective elastance, compliance, and reflected pressure waves.

95 e of interventions that are known to improve compliance, and the use of performance measures focused

96 s were omitted at random to simulate reduced compliance, and the variability of the home monitored fi

97 ilation, end-expiratory lung volume, dynamic compliance, and ventilation homogeneity in patients with

98 rovements in oxygenation, respiratory static compliance, and wet-to-dry ratios comparable to bone mar

99 ravaginal gels, and how these relate to user compliance are also summarised.

100 d require the private sector to include full compliance as a market criterion, while state and federa

101 ent Trial to test whether pulmonary arterial compliance at baseline and over the course of treatment

102 , with significantly higher tidal volume and compliance at PEEP10 and PEEP5 than PEEP20.

103 It targets GF claim compliance at the serving-size level (of a pouch or appr

104 long-term treatment that circumvents patient compliance barriers compared to current treatment via ey

105 food business operators and presents data on compliance between calculated values and analytically de

106 quired for sites with less rigorous protocol compliance, but in general, SUV is a highly repeatable i

107 To track compliance by an interprofessional team with the Awakeni

108 isks of drug resistance, and improve patient compliance by enabling oral administration.

109 orto-femoral pulse wave velocity, capacitive compliance (C1), and oscillatory compliance (C2) in the

110 capacitive compliance (C1), and oscillatory compliance (C2) in the Bogalusa Heart Study, with the pu

111 follow-up duration: 1) number of recalls; 2) compliance, calculated from registered attendance; 3) pe

112 ltaP [PIP minus PEEP], tidal volume, dynamic compliance [Cdyn]) or oxygenation (PaO2/FIO2) was associ

113 e changing baseline values lead to potential compliance challenges with frameworks such as the Energy

114 In per-protocol analyses, adjusted for non-compliance, colorectal cancer incidence and mortality we

115 ition research often lacks robust markers of compliance, complicating the interpretation of clinical

116 with potentially large implications for both compliance costs and emissions.

117 Future regulatory design will minimize compliance costs and HEC tradeoffs by regulating air, wa

118 ant in two respects: (1) they can reduce the compliance costs of the standards, and (2) they can sign

119 its, fuel-switching benefits, and regulatory compliance costs.

120 Regulatory compliance data were collected to calculate annual conta

121 mm Hg/mL, respectively; p < 0.001), vascular compliance decreased (from 2.76 +/- 0.86 to 1.48 +/- 0.3

122 ion according to the best respiratory-system compliance decreases 28-day mortality of patients with m

123 ponses to exercise, lower pulmonary arterial compliance, depressed right ventricular ejection fractio

124 s, we demonstrate that dead space and static compliance determine the effect of ECCO2R on driving pre

125 Pulmonary arterial compliance did not independently predict outcomes at bas

126 is destroyed, which leads to decreased lung compliance, disrupted gas exchange, and ultimately respi

127 otal compliance (all or none) or for partial compliance ("dose" or number of bundle elements used) an

128 ool]), blinding (outcome), co-interventions, compliance, dropouts, timing, and intention to treat.

129 atient safety when monitoring for medication compliance, drug substitution, or misuse/abuse and requi

130 piratory pressure level resulting in highest compliance during a decremental positive end-expiratory

131 .Metabolomic profiling may be used to assess compliance during clinical nutrition trials and the vali

132 There was no correlation between compliance during EVLP and duration of mechanical ventil

133 rapy and initiated letrozole, with excellent compliance during the interval 6-year period.

134 xicity with current HIV-1 drugs, and patient compliance for lifelong, daily treatment regimens.

135 y was quantified by muscle displacements and compliance from the Myotonometer measurements and resist

136 When compared with low compliance, the high compliance group had an absolute risk reduction of 3.6%

137 Peri-implant maintenance compliance >/=2 PIMT/year seems to be crucial to prevent

138 Low compliance had an average episodic cost of $20,046 (95%

139 0,046 (95% CI, $17,281-$22,812) whereas high compliance had an episodic cost of $15,272 (95% CI, $14,

140 Baseline pulmonary arterial compliance (hazard ratio, 1.18 per interquartile range o

141 Engagement measures included compliance (ie, the mean [95% margin of error] number of

142 the prognostic impact of pulmonary arterial compliance in acute respiratory distress syndrome is not

143 ist (ALT-803) improved airway resistance and compliance in an experimental asthma model.

144 of administration will improve adherence and compliance in children.

145 maging studies have investigated social norm compliance in healthy individuals, leading to the identi

146 responsiveness (AHR), airway resistance, and compliance in response to methacholine.

147 independent vasodilators as well as vascular compliance in the setting of severe HF.

148 nificant decrease of muscle displacement and compliance in the spastic muscles as compared to the con

149 ant constructs to modulate contractility and compliance in the underlying endoderm, we find that MET

150 of delirium and coma with both total bundle compliance (incident rate ratio, 1.02; 95% CI, 1.01-1.04

151 CI, 1.01-1.04; p = 0.004) and partial bundle compliance (incident rate ratio, 1.15; 95% CI, 1.09-1.22

152 Dynamic lung compliance increased from 38 (24-64) mL/cm H2O at baseli

153 Between day 0 and day 3, pulmonary arterial compliance increased in acute respiratory distress syndr

154 ume to DeltaPes (an estimate of dynamic lung compliance) increased (P < 0.05); finally, ventilation d

155 espiratory rate, minute volume, dynamic lung compliance, inspiratory resistance, and blood gases.

156 using a home-monitoring strategy, even when compliance is imperfect.

157 gulations and standards, the manner in which compliance is maintained and the degree of additional co

158 The classical explanation for the gating compliance is that the conformational rearrangement of a

159 eedles, which can be associated with patient compliance issues and safety concerns.

160 s single approaches (1 & 2 & 3) improved WHO compliance less (P < 0.001) and failed to improve techni

161 cal performance (P < 0.001) but improved WHO compliance less.

162 ve; and collapse, 6 cm H2O below the highest compliance level.

163 1.1 mm, without significant association with compliance level; however, positive periodontitis histor

164 This gating compliance makes hair cells especially sensitive to smal

165 udies have suggested that pulmonary arterial compliance may also predict prognosis in PAH.

166 nd World Health Organization (WHO) checklist compliance, measured for 3 months before and after inter

167 ventional deflation via a nonlinear arterial compliance model.

168 ion according to the best respiratory-system compliance (n = 501; experimental group) or a control st

169 ,417 ventilated patient-days of intervention compliance observations and 1,022 unit-months of ventila

170 CI, 1.74-4.09), initial 3-hour sepsis bundle compliance (odds ratio, 1.57; CI, 1.07-2.30), and older

171 eved this by 0.9 years despite moderate test compliance of 63%.

172 This study highlights broad non-compliance of a range of popular pet foods sold in the U

173 ow cofilin enhances the bending and twisting compliance of actin filaments.

174 the horizontal level) to introduce different compliance of arteries.

175 Treatment compliance of at least 75% is needed in MDA to control h

176 Its application to verify labelling compliance of foodstuffs suggested a high level of misla

177 Monitoring the compliance of gluten-free foods to the regulatory thresh

178 easures, such as increasing the hand hygiene compliance of HCWs and disinfection rate of environment,

179 To this end, we have measured the compliance of nuclei by applying oscillatory strains bet

180 Here we report that the passive compliance of the cochlear partition and active frequenc

181 pected end-expiratory lung volume and static compliance of the respiratory system (EELV-Cst,rs); as w

182 subcutaneous and muscle tissue, and that the compliance of the subcutaneous mimics increased linearly

183 from high to low, in the plastic and elastic compliances of cell walls along the elongation zone, but

184 Mechanical compliances of the stalk and hinge determined based on a

185 ethods require more than six months, and low compliance often leads to therapeutic failure and multid

186 istories and the possible influence of their compliance on peri-implant marginal bone level.

187 rences in early goal-directed therapy bundle compliance or hemodynamic goal achievement.

188 any benefits might be affected by imperfect compliance or increased variability in the home-monitori

189 e changes occur without altering hair-bundle compliance or the number of functional stereocilia withi

190 ; and MXF performs better in a simulated non-compliance or treatment interruption scenario.

191 as the plateau pressure, respiratory system compliance, or transpulmonary pressure.

192 TT improved nontechnical skills and WHO compliance (P < 0.001), but not technical performance; s

193 and pulmonary artery pressures and improved compliance (p < 0.05).

194 and improved lung function (lung volume and compliance; P < 0.05 compared with untreated and vehicle

195 se, for every 10% increase in partial bundle compliance, patients had a 15% higher hospital survival

196 For every 10% increase in total bundle compliance, patients had a 7% higher odds of hospital su

197 normalized ratio values and patient-related compliance problems.

198 The resistance-compliance product (resistance-compliance time) increase

199 by decreasing infusion frequency to increase compliance, promoting prophylaxis, offering alternatives

200 Instruction compliance (R-hits minus NR-hits) was significantly rela

201 adult ICU setting, and reported hand hygiene compliance rates collected via observation, were include

202 Furthermore, effects on compliance rates for antiinfective therapy within the re

203 tment completion and monthly follow-up visit compliance rates were higher in the 12-week RPT/INH grou

204 Improved compliance reduced hospital mortality from 4% to 2%.

205 Baseline pulmonary arterial compliance remained predictive of mortality when pulmona

206 ry distress syndrome, and pulmonary arterial compliance remains predictive even when pulmonary vascul

207 of pulsatile aortic load, including arterial compliance, resistance, elastance, and wave reflection.

208 odds of survival per 10% increase in bundle compliance, respectively, p < 0.001) in a sensitivity an

209 RC); secondary end points included toxicity, compliance, response, progression-free survival, and ove

210 bit, appear to be factors that influence the compliance risk profile (NCT02789306).

211 al media approach refined towards regulatory compliance showed expression of markers indicative of th

212 metal-like thermal conductivity, an elastic compliance similar to soft biological tissue (Young's mo

213 prepare mineralized bone that increases its compliance so that it can be embedded and easily section

214 contralateral: 6.02 +/- 0.49 mm, p = 0.038; compliance: spastic: 1.79 +/- 0.12 mm/N, contralateral:

215 n of contractile stress: Asymmetric filament compliance, spatial heterogeneity of motor activity, rev

216 ners' treatment, and relied more on positive compliance strategies than traditional officers.

217 leration trade-offs play a role in automaker compliance strategies with potentially large implication

218 ictest levels) and against two commonly used compliance strategies.

219 Thus, CCS will likely be a minor CPP compliance strategy but may play a larger role under a s

220 h periodontitis history demonstrated greater compliance than patients without periodontitis history d

221 ed periodontal treatment demonstrated better compliance than those without prior periodontal therapy

222 roval, with waiver of consent and with HIPAA compliance, the authors retrospectively analyzed DTI ima

223 When compared with low compliance, the high compliance group had an absolute ri

224 Tidal volume, static compliance, tidal impedance variation, end-expiratory lu

225 he resistance-compliance product (resistance-compliance time) increased in survivors compared with no

226 ther showed improved hospital mortality with compliance to first-hour and stabilization guideline rec

227 ged for bioactive RNA ligands, including: 1) Compliance to medicinal chemistry rules, 2) distinctive

228 mporally specific requirement of bulk tissue compliance to regulate heart development and MET.

229 This retrospective study aims to assess compliance to supportive periodontal therapy (SPT) among

230 olic and antiresorptive therapies, to assess compliance to therapy, or to indicate possible secondary

231 arly septic shock recognition and first-hour compliance to these guidelines.

232 non-completion of the primary endpoint, non-compliance to treatment (ascertained by patient report),

233 ldren because of low dietary intakes and low compliance to vitamin D supplementation policies.

234 reatment completion, monthly follow-up visit compliance, transaminase elevations, and adverse reactio

235 Insurance Portability and Accountability Act compliance under waiver of consent, a cohort of women fr

236 ment with, surfaces of varying roughness and compliance under wetted high-shear conditions using an a

237 Sensitivity analysis for vaccine compliance, vaccine efficacy and vaccine start date was

238 Mean (SD) objective compliance was 6.6 (1.4) h/night with the effective mand

239 port was for 51 (36 to 78) days, and overall compliance was 96%.

240 Compliance was associated with 86% fewer conditions of p

241 In three independent cohorts, 3-hour bundle compliance was associated with improved survival and cos

242 PRO compliance was greater than 90% at baseline and approxim

243 Higher bundle compliance was independently associated with improved su

244 Outcomes and compliance was measured for eight periods of 6 months ea

245 The total time with turning compliance was significantly different in the interventi

246 Compliance was similar across the modules: loving-kindne

247 The probability of PIMT compliance was substantially associated with frequency o

248 Compliance was tested by 24-h urinary nitrogen excretion

249 Airway inflammation, AHR, resistance, and compliance were assessed in Il15 gene-deficient mice and

250 ts in all groups and data on foods eaten and compliance were collected.

251 Total and partial bundle compliance were measured daily.

252 country differences in children's daily MVPA compliance were observed, reflecting not only site chara

253 n zone, but plots of growth rate versus wall compliances were strikingly nonlinear.

254 ower peak loads because of the higher sample compliance when fewer unit cells span the intact region.

255 primary outcomes were hospital mortality and compliance with 6-hour bundle.

256 Drug surveillance was done to ensure patient compliance with absence of antihypertensive medication.

257 Compliance with all evidence-based interventions improve

258 However, HCW acceptance and compliance with available latent tuberculosis infection

259 ine-2,3-diones via the 6-exo-trig process in compliance with Baldwin's rule.

260 We studied compliance with blood pressure (BP) goals during VPI and

261 Improving compliance with bundled infection prevention approaches

262 Compliance with completing the HRQoL questionnaire was 8

263 t food sold in the UK was measured to assess compliance with EU guidelines.

264 However, all the analysed foods were in compliance with EU legislation concerning the maximum li

265 ed intervention was associated with improved compliance with evidence-based interventions and decreas

266 al accused of noncompliance; and 3) ensuring compliance with federal regulations.

267 Compliance with home EN was excellent, but weight, muscl

268 ilable that might improve HCW acceptance and compliance with LTBI treatment.

269 ch less prone to user input errors, improves compliance with minimum information reporting guidelines

270 this study was to describe children's daily compliance with moderate-to-vigorous physical activity (

271 s are used regularly in most Thai hospitals, compliance with more comprehensive bundled prevention ap

272 Defect-free care (defined as 100% compliance with performance measures) was similar in bot

273 cteristics, infection control practices, and compliance with prevention bundles impacted multidrug-re

274 ntage of fish oil products reported to be in compliance with primary oxidation limits and EPA/DHA con

275 ealth outcomes to reimbursement are based on compliance with process measures, with less emphasis on

276 h a reduction in mortality and with improved compliance with quality indicators.

277 tion of the food supply could lead to higher compliance with recommendations in both the United State

278 Compliance with resuscitation bundle elements was signif

279 to broad-spectrum antiinfective therapy, and compliance with resuscitation bundle elements.

280 Despite greater severity and worse compliance with resuscitation bundles, mortality was low

281 harming patient safety, providing sufficient compliance with standard precautions and ongoing surveil

282 lysis restricted to participants with >/=95% compliance with study medication, PARI did provide furth

283 Mean compliance with supplementation was 87%, assessed by mon

284 ring the first period with the eigth period, compliance with the 6-hour bundle increased from 13.5% t

285 neuroimaging data organized and described in compliance with the Brain Imaging Data Structure (BIDS).

286 Confirming compliance with the dietary regimen, we found that by th

287 that, from the landowner's perspective, full compliance with the Forest Code offers few economic bene

288 ated with decreases in MDR-AB rates, greater compliance with the MDR-AB prevention bundle did not lea

289 as the attainment of population equilibrium, compliance with the molecular-clock hypothesis, or stabi

290 Facilities with >/=75% compliance with the MRSA prevention bundle experienced a

291 prescribe exhaustive/specific approaches for compliance with the new NIH policy.

292 romoting antibiotics by oral route, checking compliance with the protocol, and avoiding the unnecessa

293 Specifically, temporary sharing increases compliance with the request to take a selfie (study 1) a

294 In addition, compliance with the resuscitation bundle was worse in th

295 ory of drug intolerance, and history of poor compliance with the study drug.

296 During the post phase, overall compliance with the Surviving Sepsis Campaign (SSC) bund

297 velop ways to enhance patient acceptance and compliance with these effective drugs, and to continue t

298 Earlier recognition and compliance with treatment bundles has fortunately led to

299 e degree of IVM implementation, the level of compliance with WHO guidelines, and concordance in the u

300 ed States, trying to quit is associated with compliance with yearly dental visits and higher odds of